[ET Net News Agency, 19 August 2019] CSPC Pharmaceutical Group Limited (01093) said its
profit attributable to shareholders was RMB1.88 billion for the six months ended 30 June
2019, a year-on-year increase of 24.8%. The basic earnings per share were RMB30.13 cents.
No dividend will be distributed.
The total revenue was RMB11.18 billion, a year-on-year increase of 27.6%. The gross
profit was RMB7.81 billion, a year-on-year increase of 39.6%. (RC)